Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission
Crossref DOI link: https://doi.org/10.1007/s11864-021-00860-1
Published Online: 2021-06-07
Published Print: 2021-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arslan, Shukaib
Pullarkat, Vinod
Aldoss, Ibrahim
Text and Data Mining valid from 2021-06-07
Version of Record valid from 2021-06-07
Article History
Accepted: 31 March 2021
First Online: 7 June 2021
Declarations
:
: Based on the disclosure forms received, none of the authors has any potential conflicts of interest to disclose